[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]

Bull Cancer Radiother. 1996;83(4):314-20.

[Article in French]

Authors

J C Horiot¹, P Bontemps, A C Begg, R Le Fur, W Van den Bogaert, M Bolla, T N'Guyen, D Van den Weijngaert, J Bernier, A Lusinchi, D Stuschke, D Lopez Torrecilla, B Jancar, L Collette, M Van Glabbeke, M Pierart

Affiliation

¹ Centre Georges-François-Leclerc, Dijon, France.

PMID: 9081333

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase III
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Actuarial Analysis
Carcinoma, Squamous Cell / pathology
Carcinoma, Squamous Cell / radiotherapy*
Follow-Up Studies
Head and Neck Neoplasms / pathology
Head and Neck Neoplasms / radiotherapy*
Humans
Neoplasm Staging
Oropharyngeal Neoplasms / pathology
Oropharyngeal Neoplasms / radiotherapy
Radiotherapy / adverse effects
Radiotherapy / methods
Radiotherapy Dosage
Survival Rate
Time Factors